Shenling Baizhu San supresses colitis associated colorectal cancer through inhibition of epithelial-mesenchymal transition and myeloid-derived suppressor infiltration

AbstractsBackgroundShenling Baizhu San (SBS) is a well-known and classical Chinese medicine formula. It has been used for treatment of gastrointestinal disorders for about nine hundred years. Recent reports showed that it was effective in curing colitis and ameliorating the major manifestations of postoperational colorectal cancer (CRC). This study was to evaluate the effects of SBS on azoxymethane (AOM) and dextran sodium sulfate (DSS) induced colitis associated CRC (caCRC) and to analyze the underlying mechanism of SBS in preventing CRC.MethodsThe colon tissue of mice in different group was determined by immunohistochemistry and western blot. TGF-β1 in serum was measured by ELISA. Myeloid-derived suppressor cells (MDSCs) were identified by flow cytometry and immunohistochemistry.ResultsThe formed neoplasms phenotypically resembled human caCRC with upregulated β-catenin, p53 and proliferating cell nuclear antigen (PCNA). SBS treatment reduced the death rate of mice and decreased the incidence and multiplicity of colonic neoplasms. SBS decreased the number of MDSCs and the level of transforming growth factor β1 (TGF-β1). SBS alleviated epithelial mesenchymal transition (EMT) through downregulating N-cadherin (N-cad), Vimentin, Fibronectin, Snail, and upregulating E-cadherin (E-cad). It reduced the activation of Wnt5a and EMT induced by TGF-β1.ConclusionsSBS reduced the death rate through decreasing the incidence and multiplicity of colonic tumors. SBS lowered MDSCs infiltration and inhibited TGF-β1 induced EMT to exert its anti-caCRC effects.

[1]  Yu Sun,et al.  MicroRNA‐200b Stimulates Tumour Growth in TGFBR2‐Null Colorectal Cancers by Negatively Regulating p27/kip1 , 2014, Journal of cellular physiology.

[2]  Lianyu Chen,et al.  Tumor Microenvironment Varies under Different TCM ZHENG Models and Correlates with Treatment Response to Herbal Medicine , 2012, Evidence-based complementary and alternative medicine : eCAM.

[3]  M. Bittner,et al.  The Wnt5A/Protein Kinase C Pathway Mediates Motility in Melanoma Cells via the Inhibition of Metastasis Suppressors and Initiation of an Epithelial to Mesenchymal Transition* , 2007, Journal of Biological Chemistry.

[4]  M. Katoh,et al.  Transcriptional mechanisms of WNT5A based on NF-kappaB, Hedgehog, TGFbeta, and Notch signaling cascades. , 2009, International journal of molecular medicine.

[5]  Y. Kawakami,et al.  Improvement of Cancer Immunotherapy by Combining Molecular Targeted Therapy , 2013, Front. Oncol..

[6]  M. Katoh,et al.  Transcriptional mechanisms of WNT5A based on NF-κB, Hedgehog, TGFβ, and Notch signaling cascades , 2009 .

[7]  E. Yazlovitskaya,et al.  Prolonged wild-type p53 protein accumulation and cisplatin resistance. , 2001, Biochemical and biophysical research communications.

[8]  J. Geng,et al.  Panax ginseng polysaccharide suppresses metastasis via modulating Twist expression in gastric cancer. , 2013, International journal of biological macromolecules.

[9]  C. Ratto,et al.  Prognostic factors in colorectal cancer , 1998, Diseases of the colon and rectum.

[10]  Hui Wang,et al.  Natural Product Ginsenoside 25-OCH3-PPD Inhibits Breast Cancer Growth and Metastasis through Down-Regulating MDM2 , 2012, PloS one.

[11]  M E Hammond,et al.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. , 2000, Archives of pathology & laboratory medicine.

[12]  William C Hines,et al.  Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression , 2011, Nature Medicine.

[13]  J. Thiery,et al.  Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor , 2011, PLoS biology.

[14]  M. Sade-Feldman,et al.  New insights into chronic inflammation-induced immunosuppression. , 2012, Seminars in cancer biology.

[15]  Hyeyoung Min,et al.  T Cell Stimulatory Effects of Korean Red Ginseng through Modulation of Myeloid-Derived Suppressor Cells , 2011, Journal of ginseng research.

[16]  R. Schreiber,et al.  Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.

[17]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[18]  A. Sevko,et al.  Myeloid-Derived Suppressor Cells Interact with Tumors in Terms of Myelopoiesis, Tumorigenesis and Immunosuppression: Thick as Thieves , 2012, Journal of Cancer.

[19]  H. Qin,et al.  Epithelial-mesenchymal transition and its role in the pathogenesis of colorectal cancer. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[20]  Ge Zhang,et al.  Epithelial–Mesenchymal Transition (EMT) Induced by TNF-α Requires AKT/GSK-3β-Mediated Stabilization of Snail in Colorectal Cancer , 2013, PloS one.

[21]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[22]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[23]  A. Darzi,et al.  Epithelial mesenchymal transition in colorectal cancer: Seminal role in promoting disease progression and resistance to neoadjuvant therapy. , 2012, Surgical oncology.

[24]  F. Sipos,et al.  Epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions in the colon. , 2012, World journal of gastroenterology.

[25]  Jeffrey L. Wrana,et al.  Signal integration in TGF-β, WNT, and Hippo pathways , 2013, F1000prime reports.

[26]  Jing Zhang,et al.  Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells , 2013, BMC Cancer.

[27]  R. Derynck,et al.  Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transition. , 2014, Current opinion in cell biology.

[28]  Graham M Lord,et al.  Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells. , 2009, Cancer cell.

[29]  R. Serra,et al.  Wnt5a as an Effector of TGFβ in Mammary Development and Cancer , 2011, Journal of Mammary Gland Biology and Neoplasia.

[30]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[31]  C. Heldin,et al.  TGFβ-induced invasion of prostate cancer cells is promoted by c-Jun-dependent transcriptional activation of Snail1 , 2014, Cell cycle.

[32]  S. Tejpar,et al.  TGF-beta modulates beta-Catenin stability and signaling in mesenchymal proliferations. , 2007, Experimental cell research.

[33]  W. Wu,et al.  2,3′,4,4′,5′‐Pentamethoxy‐trans‐stilbene, a resveratrol derivative, inhibits colitis‐associated colorectal carcinogenesis in mice , 2010, British journal of pharmacology.

[34]  N. Beauchemin.  The Colorectal Tumor Microenvironment: The Next Decade , 2011, Cancer Microenvironment.

[35]  R. Langer,et al.  Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors. , 2013, Cancer cell.

[36]  Meng Shao,et al.  ShaoYao decoction ameliorates colitis-associated colorectal cancer by downregulating proinflammatory cytokines and promoting epithelial-mesenchymal transition , 2014, Journal of Translational Medicine.